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Pedro E. Antunes, David Prieto, Luís Eugénio, and Manuel J. Antunes, Coimbra, PortugalCardiac transplantation has become a relatively commonprocedure, but its major limiting factor is still theshortage of donor hearts. The donor pool can poten-tially be increased by relaxing selection criteria or by
performing innovative procedures on the donor heart, such as
valve repair. We present a recent case of successful transplantation
after mitral valve repair in a heart with moderate rheumatic valve
disease.
Clinical Summary
A 52-year-old man with end-stage congestive heart failure
caused by idiopathic dilated cardiomyopathy was evaluated and
listed for cardiac transplantation. On January 18, 2004, a 35-
year-old woman without a history of cardiac disease experi-
enced brain death from a hemorrhagic cerebral accident and was
selected as a multiorgan donor. The transthoracic echocardio-
gram showed evidence of mildly to moderately sclerotic leaflets
with otherwise good motion and no evidence of stenosis (mitral
valve area, 3.0 cm2) and mild mitral regurgitation. Regional and
global myocardial contractility was unimpaired, and the ejec-
tion fraction was normal. Because there were no other contra-
indications to heart donation, we decided to proceed with the
transplantation.
The heart was transported to our center, and the mitral valve
was carefully inspected through the open left atrium. The free
edges of the leaflets were mildly fibrosed and retracted, and the
posteromedial commissure was moderately fused, as were the
corresponding chordae tendineae. The valve was tested with in-
jection of cold saline into the left ventricle after the aorta was
clamped. There was a central jet of regurgitation caused by in-
complete coaptation of the leaflets as a result of some retraction of
the free edges. Because the valve disease was thought to be more
significant than anticipated before the heart procurement, it was
decided to proceed to bench repair of the mitral valve. A commis-
surotomy of the posteromedial commissure, followed by division
of fused chordae tendineae, was performed. Additionally, although
there was only mild annular enlargement, an annuloplasty was
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let coaptation and to prevent future
annular enlargement. The posterior
annulus was plicated with a double
continuous 3-0 polyester suture
placed from trigone to trigone (Figure
1). The valve was again tested, and
good coaptation of the leaflets was
observed. This was a straightforward
procedure with understandably excellent exposure, and it required
less than 10 minutes of additional ischemic time.
The heart was them implanted by a bicaval anastomotic tech-
nique. The crossclamp time was 35 minutes. The ischemic time of
the donor heart was 84 minutes. Intraoperative transesophageal
echocardiography revealed minimal mitral regurgitation. Donor
heart function was excellent. There was no transvalvular gradient,
as determined by direct measurement of simultaneous left ventric-
ular and left atrial pressures.
Discussion
Cardiac transplantation has become a relatively common proce-
dure, with the major limiting factor being the shortage of donor
hearts. A more immediate solution is to increase the yield of hearts
from currently available donors. Originally based on the experi-
ence at Stanford, the criteria for donor selection have been ex-
panded, and factors that made a heart unacceptable for transplan-
tation are changing. In this context several recommendations have
been made recently to expand the donor pool effectively without
increasing the risk of adverse outcomes.1
One of these is related to valvular dysfunction, considering that
in some cases bench repair can be performed on a donor heart with
mild or moderate mitral or tricuspid regurgitation. Considering our
own excellent results with mitral valve repair for mitral stenosis
and annular dilatation,2 we believed we were justified to proceed
with conventional mitral valve repair in this situation.
In the literature we could find reports of only 3 cases of mitral
valve repair in valves without organic involvement in which the
regurgitation was caused by annular dilatation.3,4 On the other
hand, the presence of organic valve disease in a donor heart is
usually considered an absolute contraindication to cardiac dona-
tion. To our knowledge, the only other case of repair of organic
mitral valve disease (ie, open mitral commissurotomy) before
orthotopic transplantation was reported in 1994.5 The authors
justified the decision mainly on the critical condition of the patient.
We report a case a mitral valve repair (commissurotomy plus
annuloplasty) in a mildly dysfunctional valve caused by a rheu-
matic process. Our decision was made because we thought that the
donor mitral valve could be made competent and the functional
area could be slightly increased without detriment to the left
ventricular function or compromise of the long-term durability of
the organ. But this remains to be confirmed. However, we believe
that immunosuppression therapy, especially steroids, can only
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Salmonella infection in an anterior mediastinal mass
Yvonne M. Carter, MD,a Lamia Shagrun, MD,b Harvey Klein, MD,b Jeffrey Katz, MD,c and David M. Jablons, MD,a
Figure 1. Technique of posterior annular plication used in this case.Salmonella infection occurs through fecal-oral transmis-sion and usually appears in the biliary tract in the rareinstance that it is extraintestinal. Thoracic Salmonellainfection is rare1-3 and has never been reported in the
thymus. One case attributes a Salmonella thyroid abscess to the
immunosuppressive therapy for myasthenia gravis.4 There has
been only one previous report of thymic abscess in an adult in the
literature.5 We report the first description of a Salmonella bacte-
remia associated with a thymic abscess within a thymoma.
Clinical Summary
Six years before presentation, a 55-year-old woman was found to
have a large, anterior mediastinal mass on routine chest radiogra-
phy. It was presumed to be a thymoma at that time, and she
declined further diagnostic or therapeutic intervention.
At the time of presentation, the patient reported a 3-day history
of fevers, polyarthralgias, rigors, chills, and pleuritic chest pain.
She denied any symptoms suggestive of myasthenia gravis. Her
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Significant clinical findings on admission were a temperature of
101.7°F and a blood pressure of 90/50 mm Hg. Her white blood
cell count was 24,600/L, with 66% polymorphonuclear cells and
17% bands. With prophylactic antibiotics, her white blood cell
Figure 1. Chest computed tomographic scan of the 8  10–cm
calcified mass in the anterior superior right mediastinum.count decreased to 13,000/L; however, she continued to have
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